⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer
globenewswire.com
SLS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Novartis AG (NVS) And Encourages Shareholders to Connect
accessnewswire.com
NVS
RYDE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Ryde Group Ltd Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
RYDE
LINC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lincoln Educational Services Corporation Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
LINC
FCEL SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that FuelCell Energy, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
FCEL
Bronstein, Gewirtz & Grossman, LLC Encourages Tyra Biosciences, Inc. (TYRA) Stockholders to Inquire about Securities Investigation
accessnewswire.com
TYRA
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enova International, Inc. (ENVA) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
ENVA
BIDU SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Baidu, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
BIDU
Bronstein, Gewirtz & Grossman, LLC Encourages Cellectis S.A. (CLLS) Stockholders to Inquire about Securities Investigation
accessnewswire.com
CLLS
SolarEdge Technologies, Inc. (SEDG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
SEDG